Skip to main content

Share story

Infrastructure

AWS lets existing ElastiCache Valkey clusters change durability

Amazon Web Services says ElastiCache for Valkey customers can now enable or disable durability on existing node-based clusters without creating a replacement. Previously, customers could not change that configuration in place, complicating moves between caching and persistent storage. Synchronous writes persist data across at least two availability zones before responding, with single-digit millisecond write latency and a design goal of zero data loss. Asynchronous writes preserve microsecond write latency at no additional cost, but a failure could lose up to 10 seconds of uncommitted data. Both retain microsecond read latency. The feature is available wherever ElastiCache for Valkey 9.0 and later is offered.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Recent Announcements and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Former Benchmark investors raise $1.252 billion for Diffusion ONE

Former Benchmark investors Victor Lazarte and Kris Fredrickson have raised $1.252 billion for their debut AI fund, Diffusion ONE, TechCrunch reported from SEC filings. The total exceeds the $800 million target Forbes reported in M...

Products Capital
Products Capital

Hex announces $100 million financing and rebuilt analytics platform

Hex says it closed a $100 million financing round at a $1.2B valuation and introduced Hex 4.0, a rewrite of its analytics platform. PeakXV and 137 Ventures led the round, with participation from Amplify, Avra, a16z, Redpoint, Sequ...

Infrastructure Products
Infrastructure Products

ASM raises 2027 revenue forecast to more than €5.7B

ASM International raised its 2027 revenue forecast to more than €5.7B from above €4.6B forecast in July, as memory and advanced AI chipmakers expand production. The chip-equipment maker said the revised outlook would reach its 203...

Capital AI
Capital AI

Anthropic acquires Mithril Medicine and starts its own drug research

Anthropic says it has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, and begun running drug discovery programs itself. Founder Cody Tranbarger is continuing the rese...